Clinical Efficacy of Patients With Secondary Bacteremia Treated With Omadacycline: Results From Phase 3 Acute Bacterial Skin and Skin Structure Infections and Community-Acquired Bacterial Pneumonia Studies
George Sakoulas, Paul B. Eckburg, Maria Amodio-Groton, Amy Manley, Evan Tzanis, Anita Das, Robert Noble, Paul C. McGovern
Abstract
In this post hoc analysis of the 63 patients with secondary bacteremia enrolled in the 3 omadacycline phase 3 studies of acute bacterial skin/skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP), we determined that omadacycline is a viable therapeutic option for appropriate patients with secondary bacteremia.
Topics & Concepts
MedicineBacteremiaBacterial pneumoniaPneumoniaInternal medicineIntensive care medicineMicrobiologyAntibioticsBiologyAntimicrobial Resistance in StaphylococcusAntibiotic Use and ResistanceAntibiotic Resistance in Bacteria